Jmoney_ : $Globalstar (GSAT.US)$ & $Applied DNA Sciences (APDN.US)$     Your thoughts? Have these been on your radar?

Jmoney_ Jaguar8 OP : $Globalstar (GSAT.US)$  partnership with $Apple (AAPL.US)$ , collaboration w/ $Parsons (PSN.US)$ & Peiker partnership

Jmoney_ : Quantum-Si (QSI) and NVIDIA collaborate to revolutionize the health sector, specifically in proteomics—the large-scale study of proteins essential for understanding diseases and developing targeted therapies. Their partnership focuses on integrating NVIDIA’s GPUs and AI frameworks with Quantum-Si’s next-generation protein sequencing technology. Here’s a concise breakdown:
Why They Work Together
1. Protein Analysis at Scale:
Quantum-Si’s sequencing technology generates vast amounts of data. NVIDIA’s GPUs power the processing and interpretation of this data efficiently, enabling faster and more accurate analysis.
2. AI-Driven Insights:
NVIDIA provides the computational backbone for running advanced AI algorithms, allowing Quantum-Si to identify complex protein patterns and structures critical for drug discovery and personalized medicine.
3. Not Quantum Computing! :
Despite the name “Quantum-Si,” the company is not involved in quantum computing. Instead, it focuses on applying traditional computational and sequencing tools to decode the proteome, the set of all proteins in the body. NVIDIA complements this effort with its expertise in AI and computational performance.

Jmoney_ : Why This Matters for Health, Not Quantum Computing
• Targeting the Health Sector:
Both companies aim to improve disease diagnosis and treatment by understanding proteins, which are key to cellular functions and the mechanisms of diseases. Their work is firmly rooted in biosciences, not quantum mechanics.
• No Quantum Computing Involvement:
Quantum-Si uses the term “quantum” metaphorically, emphasizing a leap in technology for protein sequencing, not quantum physics. NVIDIA’s role is purely in advanced GPU-based computing.
Bottom Line:
This collaboration is about leveraging cutting-edge computational tools to advance biotechnology, specifically in protein research and healthcare applications, without any connection to quantum computing. It’s a transformative partnership in the life sciences, not physics.